Topic: Guillain Barre Syndrome

Dr. Peter Hotez is criticized for his shifting stance on vaccine technologies, specifically his recent comments regarding whole inactivated virus vaccines. Hotez argued that older vaccine technologies are prone to side effects like Guillain-Barre syndrome, citing the 1976 swine flu incident. The hosts suggest that the medical establishment is now disparaging traditional vaccines to protect the market dominance of mRNA technology.

Actor Jamie Foxx appears in a public video for the first time since his April hospitalization to address rumors about his health and vision. The timing of the video coincides with the release of his new Netflix film, "They Cloned Tyrone." Speculation regarding his medical condition includes a potential diagnosis of Guillain-Barré syndrome.

Claims have surfaced that the American Medical Association (AMA) manipulated polio eradication statistics by changing the diagnostic definition of the disease in 1954. By reclassifying paralysis cases as Guillain-Barre syndrome or meningitis, the medical establishment allegedly created an artificial drop in polio numbers. This shift in criteria is compared to modern changes in how COVID-19 cases and deaths are reported.

Ross Whiteman, a 40-year-old former pilot in British Columbia, is one of the first Canadians approved for compensation after being paralyzed by Guillain-Barre syndrome following an AstraZeneca COVID-19 vaccine. The report notes that while Whiteman has received validation, others like Sean Muldoon are still waiting for support after developing blood clots. The media coverage is analyzed for its focus on AstraZeneca over other vaccine brands.

Listeners are contributing portions of their federal Biden Child Care Tax Credits to support the show. Personal anecdotes from the community include reports of neighbors developing shingles and measles following COVID-19 vaccinations. Other producers shared stories of developing Guillain-Barre syndrome after receiving standard Tdap or tetanus shots, highlighting the risks associated with various immunizations.

A producer in Fremont, California, shared his experience living with Guillain-Barre syndrome following a tetanus vaccine, a condition that requires him to use a cane. Simultaneously, "Dame Vox" from Ketchikan, Alaska, invited the hosts to visit the state for a meetup. The invitation emphasizes the "grand adventure" of Alaska and the opportunity to see true off-the-grid living.

A WHO spokesman, Christian Lindmeier, admitted that the link between the Zika virus and microcephaly is not yet scientifically proven. He noted that other factors, including drugs, alcohol, and vaccines, can also cause microcephaly and Guillain-Barre syndrome. One host shares a personal anecdote about a family member suffering from Guillain-Barre following a vaccination.

Claims are discussed regarding the renaming of polio symptoms to Guillain-Barre syndrome in cases where vaccines fail to provide immunity. The discussion also covers the high cost of the HPV vaccine, which can reach $800 for a two-shot series. The hosts describe a "sales cycle" where doctors use inconclusive pap smear results to pressure women into purchasing expensive and potentially unnecessary vaccinations.

The rollout of the H1N1 nasal spray vaccine is analyzed using CDC Vaccination Information Statements (VIS). The hosts highlight specific warnings, such as the exclusion of pregnant women and adults over 50 from the nasal version, and the legal limitations on suing for vaccine injuries. They also note that while the federal government calls the vaccine voluntary, state laws or employers may mandate it.

The UK Health Protection Agency sent a confidential letter to 600 senior neurologists warning them to monitor for an increase in Guillain-Barre Syndrome (GBS). The warning is linked to the upcoming mass vaccination program for swine flu, as adjuvants in the vaccine may trigger the deadly nerve disease. This echoes concerns from the 1976 swine flu outbreak where the vaccine caused more deaths than the virus itself.

The US government committed nearly $1 billion to purchase H1N1 vaccine components, with the majority of funds going to Novartis for chemical adjuvants. Concerns have been raised that these "boosters" may overstimulate the immune system, potentially leading to an increase in Guillain-Barre syndrome cases.

Concerns are raised regarding the safety of the fast-tracked swine flu vaccine, referencing the 1976 outbreak where the vaccine caused hundreds of cases of Guillain-Barre syndrome. A discussion involving a former Black Panther member touches on fears that forced vaccinations and genetically modified foods could be used as tools for social engineering or targeting specific demographics. Reports of quarantines at San Quentin prison further fuel these anxieties.